Search

everythinglearnresearchcommunity

for

Search:↓

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Progesterone's seizure-reducing effects are mainly due to allopregnanolone, not progesterone receptors.

AHR ligands could treat inflammatory skin diseases.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Compound 7p shows strong potential as an anticancer agent.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Patients with lichen planopilaris have a higher risk of heart disease.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Solid Lipid Particle technology makes retinol more stable, effective, and gentle on the skin.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.